PureTech Health PLC (OTCPK:PTCHF)
$ 2 0.01 (0.5%) Market Cap: 458.92 Mil Enterprise Value: -23.08 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 48/100

PureTech Health PLC at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 03:20PM GMT
Release Date Price: $5.6 (-0.44%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Okay. Good morning, and welcome to Day 2 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biotech analyst here at Barclays. And I am pleased to welcome to the next the next slide here to PureTech Health.

Presenting for the company will be CFO, George Farmer. He's got a very interesting story here to tell you a unique business model as well as some of their own proprietary products. And with that, I'll pass it off to George. Thank you.

George Farmer
PureTech Health plc - CFO

Great. Thanks very much, Carter. Very pleased to be here at the Barclays Healthcare conference to tell the PureTech story. We have a very unique story to tell here about PureTech, which involves a highly promising therapeutic development pipeline that I'll be discussing today. We also have a number of anticipated milestones and catalysts that are expected in the back half of this year, all of which are related to our goal of developing novel medicines for serious diseases with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot